Abstract:Although abnormal activation of the sonic hedgehog (Shh) signaling pathway has been demonstrated in human hepatocellular carcinoma (HCC) patients and in most HCC cell lines, the mechanism by which the Shh pathway promotes the development of HCC remains uncertain. Using a liver cancer model induced by diethylnitrosamine (DEN) which mimics the process from liver injury, abnormal hepatocyte proliferation, and hepatocirrhosis to hepatocyte canceration, we investigated the abnormal activation of the Shh pathway by examining the expression of Shh, patched-1 (Ptch), smoothened (SMO), and glioma-associated oncogene-1 (Gli1) genes. During this process, the expression of CDK1 and cyclin B1 protein, which are two components of the M-phase promoting factor (MPF) controlling G2/M transition, was also examined to explore the potential relationship between Shh activation and cell cycle progression. We observed that the cells with Shh, Ptch, and Gli1 protein expression were mainly distributed in hyperplastic nodule, cancerous node, the epithelia of interlobular bile duct, and precancerous tissues. A gradually increasing tendency of the positive expression rate of Shh, Ptch, and Gli1 proteins in the process from the beginning normal tissue to the final cancer formation was revealed. The cyclin B1 and CDK1 expression level was higher in the DEN-induced rats as compared with normal rats, and their expression was mainly distributed in the portal area of the liver, hyperplastic nodule, cancerous node, and precancerous tissues. Our results suggested that the Shh signaling pathway is activated during liver carcinogenesis, and activated Shh signaling promotes the cell proliferation by facilitating the G2/M transition through increasing the expression of cyclin B1 and CDK1 protein, which eventually results in the development of liver cancer. Better understanding of the Shh signaling pathway in HCC may contribute to the development of novel therapeutic strategies in inhibiting cell proliferation and promoting cell cycle arrest.

Sesn3 Deficiency Promotes Carcinogen-Induced Hepatocellular Carcinoma Via Regulation of the Hedgehog Pathway.

Sestrin 3 Protects Against Diet-Induced Nonalcoholic Steatohepatitis in Mice Through Suppression of Transforming Growth Factor Signal Transduction

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Sestrin Proteins Protect Against Lipotoxicity-Induced Oxidative Stress in the Liver Via Suppression of C-Jun N-Terminal Kinases

Inhibition of Csn3 Expression Induces Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells.

SESN1, Negatively Regulated by Mir-377-3p, Suppresses Invasive Growth of Head and Neck Squamous Cell Carcinoma by Interaction with SMAD3

Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2.

Sestrin2 Protein Positively Regulates AKT Enzyme Signaling and Survival in Human Squamous Cell Carcinoma and Melanoma Cells.

Sestrin 2 Confers Primary Resistance to Sorafenib by Simultaneously Activating AKT and AMPK in Hepatocellular Carcinoma

Hepatic SIRT6 Deficit Promotes Liver Tumorigenesis in the Mice Models

Inhibition of Sesn2 has negative regulatory effects on the myogenic differentiation of C2C12 myoblasts

Sestrin2: multifaceted functions, molecular basis, and its implications in liver diseases

Deficiency of Histone Methyltransferase SET Domain-Containing 2 in Liver Leads to Abnormal Lipid Metabolism and HCC.

Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.

SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis

Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells

Sonic hedgehog signaling pathway mediates development of hepatocellular carcinoma

Novel Role of Semaphorin 3A in the Growth and Progression of Hepatocellular Carcinoma.

Sp1 is Involved in Regulation of Cystathionine Γ-Lyase Gene Expression and Biological Function by PI3K/Akt Pathway in Human Hepatocellular Carcinoma Cell Lines.

STAT3 and AKT Signaling Pathways Mediate Oncogenic Role of NRSF in Hepatocellular Carcinoma

Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice